FDA accepts Pfizer's new CRC drug application & more: 3 GI industry key notes

Here are three updates from gastroenterology companies and practices from the past week:

The FDA accepted Pfizer's supplemental New Drug Application for its combination therapy for advanced BRAF-mutant metastatic colorectal cancer and granted it priority review designation.

Check-Cap reported final results from its U.S. pilot study of its C-Scan System, a preparation-free colorectal cancer detection system.

Hattiesburg, Miss.-based Forrest General Hospital added Porter Glover, MD, Telciane Vesa, MD, and Andrew Weeks, MD, to its gastroenterology care team.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast